Perrigo Company

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 1 drug with upcoming expirations

Activity

Key Events

Mar 17, 2022FDAAsmanex Hfa — NASONEX 24HR ALLERGY

Aug 12, 2019FDAAsmanex Hfa — ASMANEX HFA

Dec 8, 2017FDAAsmanex Hfa — SINUVA

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

5 patent groups across drugs · Source: FDA Orange Book

DrugExpires

Asmanex Hfa2 patentsApr 4, 2026 Asmanex HfaJun 12, 2027 Asmanex HfaOct 3, 2031 Asmanex HfaFeb 8, 2032 Asmanex Hfa2 patentsMar 13, 2034

Regulatory

Regulatory Timeline

19872 events

FDAMay 6

Asmanex Hfa — ELOCON

Application NDA019625 (NDA)

FDAApr 30

Asmanex Hfa — ELOCON

Application NDA019543 (NDA)

19891 event

FDAMar 30

Asmanex Hfa — ELOCON

Application NDA019796 (NDA)

19971 event

FDAOct 1

Asmanex Hfa — NASONEX

Application NDA020762 (NDA)

20023 events

FDADec 19

Claritin — ALAVERT

Application NDA021375 (NDA)

FDANov 27

Claritin — CLARITIN

Application NDA020641 (NDA)

FDANov 27

Claritin — CLARITIN

Application NDA019658 (NDA)

20031 event

FDANov 19

Claritin — CLARITIN HIVES RELIEF REDITAB

Application NDA020704 (NDA)

20041 event

FDAJun 24

Claritin — LORATADINE

Application NDA021512 (NDA)

20051 event

FDAOct 4

Claritin — LORATADINE

Application NDA021734 (NDA)

20062 events

FDADec 12

Claritin — CLARITIN REDITABS

Application NDA021993 (NDA)

FDAAug 23

Claritin — CHILDREN'S CLARITIN

Application NDA021891 (NDA)

20082 events

FDAJun 16

Claritin — CLARITIN

Application NDA021952 (NDA)

FDAFeb 1

Asmanex Hfa — ASMANEX TWISTHALER

Application NDA021067 (NDA)

20171 event

FDADec 8

Asmanex Hfa — SINUVA

Application NDA209310 (NDA)

20191 event

FDAAug 12

Asmanex Hfa — ASMANEX HFA

Application NDA205641 (NDA)

20221 event

FDAMar 17

Asmanex Hfa — NASONEX 24HR ALLERGY

Application NDA215712 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)